Authors:Linawati Hananta, Indwiani Astuti, Ahmad Hamim Sadewa, Josephine Alice, Jontari Hutagalung, Mustofa
Publication date: 23 July 2018
Osong Public Health and Research Perspectives
Volume: 9(4):192-196
Link: http://www.kcdcphrp.org/journal/view.html?doi=10.24171/j.phrp.2018.9.4.08
ABSTRACT
Objectives: The CYP2B6 is one of the most polymorphic CYP genes in humans that has the potential to modify the pharmacological and toxicological responses to clinically important drugs such as antimalarial artemisinin and its derivatives. The aim of the study was to determine the frequency of CYP2B6 polymorphisms in Timor malaria endemic area, East Nusa Tenggara, Indonesia where Artemisin-based Combination Therapy (ACT) has been used to treat uncomplicated malaria.
Methods : A total of 109 healthy subjects were participate d in this study. CYP2B6*4, *6 and *9 polymorphisms were analyzed using PCR-RFLP to confirm the SNPs prevalence of 516G>T and 785A>G in exon 4 and 5
.